Learn how to use the Screener tool to winnow down the universe of mutual funds and ETFs and find attractive investments. Share Inspired by Morningstar analyst Russ Kinnel's recent guidance on choosing ...
In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...
Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).